Pedro Correa de Sampaio - bacteria against tumours
Neobe Therapeutics co-founder Pedro Correa de Sampaio on engineering bacteria to break down tumour matrix so cancer immunotherapies reach resistant patients.
About this episode
1. The Genesis of Neobe Therapeutics: Pedro co-founded Neobe Therapeutics with the aim of addressing a significant issue in the pharmaceutical industry: drug resistance in cancer treatment. Approximately 20% of cancer patients don't respond to immunotherapies, which are drugs that activate an immune response against cancer. And that is the problem Pedro & his team are trying to solve - making these drugs work in more patients by breaking down their extracellular matrix. Neobe Therapeutics' groundbreaking approach involves using engineered bacteria to overcome drug resistance, offering hope for more effective treatment options.